Kataoka M - Search Results

1

Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients.

Yanagisawa R, Kataoka M, Inami T, Shimura N, Ishiguro H, Fukuda K, Yoshino H, Satoh T. Yanagisawa R, et al. Among authors: kataoka m. Int J Cardiol. 2014 Aug 1;175(2):285-9. doi: 10.1016/j.ijcard.2014.05.011. Epub 2014 May 16. Int J Cardiol. 2014. PMID: 24874907

2

A 38-year-old man with pulmonary hypertension, who had undergone atrial septal closure 26 years previously.

Satoh T, Yagi T, Kato S, Azuma K, Kataoka M, Takahashi T, Sato A, Okita H. Satoh T, et al. Among authors: kataoka m. Keio J Med. 2003 Dec;52(4):250-62. Keio J Med. 2003. PMID: 14748478 Free article.

3

Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.

Kataoka M, Satoh T, Manabe T, Anzai T, Yoshikawa T, Mitamura H, Ogawa S. Kataoka M, et al. Intern Med. 2004 Oct;43(10):945-50. doi: 10.2169/internalmedicine.43.945. Intern Med. 2004. PMID: 15575245 Free article.

4

Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol.

Kataoka M, Satoh T, Manabe T, Anzai T, Yoshikawa T, Mitamura H, Ogawa S. Kataoka M, et al. Circ J. 2005 Apr;69(4):461-5. doi: 10.1253/circj.69.461. Circ J. 2005. PMID: 15791043 Free article. Clinical Trial.

5

Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.

Kataoka M, Satoh T, Yoshikawa T, Nakamura I, Kohno T, Yoshizawa A, Anzai T, Ogawa S. Kataoka M, et al. Circ J. 2008 Mar;72(3):358-63. doi: 10.1253/circj.72.358. Circ J. 2008. PMID: 18296829 Free article. Clinical Trial.

6

Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.

Yanagisawa R, Kataoka M, Taguchi H, Kawakami T, Tamura Y, Fukuda K, Yoshino H, Satoh T. Yanagisawa R, et al. Among authors: kataoka m. Circ J. 2012;76(5):1245-52. doi: 10.1253/circj.cj-11-1192. Epub 2012 Feb 14. Circ J. 2012. PMID: 22333215 Free article. Clinical Trial.

7

Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy.

Taguchi H, Kataoka M, Yanagisawa R, Kawakami T, Tamura Y, Fukuda K, Yoshino H, Satoh T. Taguchi H, et al. Among authors: kataoka m. Circ J. 2012;76(6):1494-500. doi: 10.1253/circj.cj-11-1223. Epub 2012 Mar 16. Circ J. 2012. PMID: 22447010 Free article.

8

Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.

Yamada Y, Okuda S, Kataoka M, Tanimoto A, Tamura Y, Abe T, Okamura T, Fukuda K, Satoh T, Kuribayashi S. Yamada Y, et al. Among authors: kataoka m. Circ J. 2012;76(7):1737-43. doi: 10.1253/circj.cj-11-1237. Epub 2012 Apr 12. Circ J. 2012. PMID: 22498565 Free article.

9

Left ventricular dysfunction due to diffuse multiple vessel coronary artery spasm can be concealed in dilated cardiomyopathy.

Inami T, Kataoka M, Shimura N, Ishiguro H, Kohshoh H, Taguchi H, Yanagisawa R, Hara Y, Satoh T, Yoshino H. Inami T, et al. Among authors: kataoka m. Eur J Heart Fail. 2012 Oct;14(10):1130-8. doi: 10.1093/eurjhf/hfs103. Epub 2012 Jun 19. Eur J Heart Fail. 2012. PMID: 22713288 Free article.

10

Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension.

Tamura Y, Ono T, Sano M, Fukuda K, Kataoka M, Satoh T. Tamura Y, et al. Among authors: kataoka m. Am J Respir Crit Care Med. 2012 Aug 1;186(3):291-2. doi: 10.1164/ajrccm.186.3.291. Am J Respir Crit Care Med. 2012. PMID: 22855545 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,898 results

Search Page

Filters